ADAPTIVE THERAPEUTICS Trademark

Trademark Overview


On Tuesday, March 21, 2017, a trademark application was filed for ADAPTIVE THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ADAPTIVE THERAPEUTICS trademark a serial number of 87380024. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, August 30, 2018. This trademark is owned by Adaptive Biotechnologies. The ADAPTIVE THERAPEUTICS trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Targeted T-cell receptor sequences, engineered T-cell receptor sequences, and therapeutics derived from natural T-cell receptor sequences for use in the treatment of cancer, autoimmune disease and infectious diseases

Scientific research, development and analytical services for discovery and identification of T-cell receptor sequences specific for an antigen or for development or use as a therapeutic, therapeutic target or biomarker; scientific research, development, and analytical services in the fields of medicine, oncology, auto-immune disorders, infectious diseases, immunology, immunotherapies, immunopharmaceuticals, immune repertoire sequencing, T-cell therapeutics, therapeutics, and therapeutic technologies
adaptive therapeutics

General Information


Serial Number87380024
Word MarkADAPTIVE THERAPEUTICS
Filing DateTuesday, March 21, 2017
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, August 30, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesTargeted T-cell receptor sequences, engineered T-cell receptor sequences, and therapeutics derived from natural T-cell receptor sequences for use in the treatment of cancer, autoimmune disease and infectious diseases
Goods and ServicesScientific research, development and analytical services for discovery and identification of T-cell receptor sequences specific for an antigen or for development or use as a therapeutic, therapeutic target or biomarker; scientific research, development, and analytical services in the fields of medicine, oncology, auto-immune disorders, infectious diseases, immunology, immunotherapies, immunopharmaceuticals, immune repertoire sequencing, T-cell therapeutics, therapeutics, and therapeutic technologies

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, March 24, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, March 24, 2017
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAdaptive Biotechnologies
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSeattle, WA 98102

Trademark Events


Event DateEvent Description
Thursday, August 30, 2018ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, August 30, 2018ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, August 29, 2018ASSIGNED TO EXAMINER
Tuesday, February 13, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 29, 2018NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Monday, January 29, 2018SUBSEQUENT FINAL EMAILED
Monday, January 29, 2018SUBSEQUENT FINAL REFUSAL WRITTEN
Saturday, December 16, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, December 15, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 15, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 12, 2017NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Thursday, October 12, 2017NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
Thursday, October 12, 2017REPORT UNRESPONSIVE AMENDMENT - COMPLETED
Saturday, August 26, 2017NOTIFICATION OF FINAL REFUSAL EMAILED
Saturday, August 26, 2017FINAL REFUSAL E-MAILED
Saturday, August 26, 2017FINAL REFUSAL WRITTEN
Wednesday, August 2, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 2, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, July 31, 2017ASSIGNED TO LIE
Tuesday, June 27, 2017TEAS VOLUNTARY AMENDMENT RECEIVED
Wednesday, June 21, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 21, 2017NON-FINAL ACTION E-MAILED
Wednesday, June 21, 2017NON-FINAL ACTION WRITTEN
Wednesday, June 14, 2017ASSIGNED TO EXAMINER
Friday, March 24, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, March 24, 2017NEW APPLICATION ENTERED IN TRAM